MOTS-c: Mitochondrial-Derived Peptide Mechanism and Laboratory Research Notes

This article is a research-only summary intended for qualified laboratory researchers. MOTS-c is a research peptide. It is not approved for human use by the FDA or any other regulatory authority and is not intended to diagnose, treat, cure, or prevent any condition. Nothing on this page constitutes medical advice.

What is MOTS-c?

MOTS-c (mitochondrial open reading frame of the 12S rRNA-c) is a 16-amino-acid peptide encoded within the mitochondrial genome. It was first characterized in the published literature in 2015 as a member of a class of mitochondrial-derived peptides (MDPs) — short peptides whose coding sequences are embedded in mitochondrial DNA rather than nuclear DNA. This makes MOTS-c structurally and functionally distinct from the nuclear-DNA-encoded peptides that dominate the broader research peptide catalog.

For laboratory researchers, MOTS-c is studied in published preclinical models for its observed effects on mitochondrial-pathway markers, metabolic-pathway markers, and aging-related cellular endpoints in rodent and cell-culture studies.

Investigated mechanisms in the published literature

1. Mitochondrial-derived peptide biology

The defining feature of MOTS-c is its mitochondrial origin. Most peptides studied in laboratory research are translated from nuclear-encoded genes; MOTS-c is one of a small number of peptides where the coding sequence sits inside the mitochondrial genome itself. This biological positioning has made MOTS-c a recurring topic in the published mitochondrial-biology and aging-research literature.

2. Metabolic-pathway markers

Published preclinical studies in rodent models have reported observed changes in metabolic-pathway markers — particularly markers associated with glucose-handling pathways and insulin-signaling pathways — following administration of MOTS-c to research animals. These remain laboratory observations in preclinical research.

3. AMPK pathway signaling

A subset of the published preclinical literature has reported observed activation of AMP-activated protein kinase (AMPK) pathway markers in cell-culture and rodent models following MOTS-c administration. AMPK is a central energy-sensing pathway in cellular biology, and the AMPK-pathway-marker observations are one of the most-cited mechanism findings in the published MOTS-c literature.

4. Mitochondrial-function markers

Published preclinical work has reported observed changes in mitochondrial-function markers — including markers associated with mitochondrial biogenesis pathways and oxidative phosphorylation pathways — in cell-culture and rodent models exposed to MOTS-c. These findings are consistent with MOTS-c’s mitochondrial origin and have driven much of the published interest in this peptide class.

5. Aging-related endpoints

A portion of the published preclinical MOTS-c literature focuses on aging-related cellular endpoints in rodent models. Observed changes in age-associated metabolic markers have been reported in this preclinical research. As with all preclinical findings, these are laboratory observations and not clinical claims.

MOTS-c in the broader mitochondrial peptide research class

MOTS-c is one of several mitochondrial-derived peptides characterized in the published literature. Other members of the class include humanin and the SHLP series. MOTS-c is distinguished within the class by being one of the most-studied MDPs in the published metabolic-pathway research literature.

For comparison with another mitochondrial-pathway research peptide in a different mechanism class, see our SS-31 (elamipretide) research peptide article — SS-31 is a mitochondrial-targeted research peptide with a distinct mechanism (cardiolipin binding and electron-transport-chain stability) rather than the AMPK-pathway focus of MOTS-c.

Available research vial sizes

Pure Chain Aminos carries MOTS-c research peptide as a high-mass research vial:

• MOTS-c 40mg — research vial

Each vial ships with its production batch’s third-party Certificate of Analysis verifying purity by HPLC and identity by mass spectrometry.

Reconstitution and stability research

MOTS-c is typically supplied as a lyophilized white powder. Standard reconstitution uses bacteriostatic water as the diluent — see our bacteriostatic water and peptide reconstitution guide for the standard laboratory reconstitution principles, concentration math, and storage notes.

For a 40mg MOTS-c research vial, the reconstitution math follows the standard formula: Concentration (mg/mL) = Peptide mass (mg) ÷ Diluent volume (mL). Common reconstitutions for a 40mg vial:

Vial	Diluent added	Resulting concentration
40mg MOTS-c	2.0 mL bac water	20 mg/mL (= 20,000 mcg/mL)
40mg MOTS-c	4.0 mL bac water	10 mg/mL (= 10,000 mcg/mL)
40mg MOTS-c	5.0 mL bac water	8 mg/mL (= 8,000 mcg/mL)

Quality control considerations

Standard QC for MOTS-c research peptide typically involves:

• HPLC purity verification — confirms the lyophilized peptide meets the laboratory’s purity threshold (commonly >98%).
• Mass spectrometry identity confirmation — confirms the peptide’s molecular weight matches the expected sequence.
• Batch-level Certificate of Analysis — included with every Pure Chain Aminos research vial.

Open questions in the published literature

Receptor identification. The exact cellular receptor(s) mediating the observed MOTS-c effects in preclinical models is still an active area of published research. The AMPK-pathway-marker findings are well-replicated; the upstream binding partner is less settled in the published literature.

Pharmacokinetics across species. The vast majority of published MOTS-c research data comes from rodent and cell-culture preclinical models. Translation across species pharmacokinetics remains an open research question.

Half-life engineering. Native MOTS-c is a relatively short peptide and the published literature includes ongoing investigation into modified MOTS-c variants designed to extend in-laboratory stability.

Frequently asked research questions

What does MOTS-c stand for?
MOTS-c stands for “mitochondrial open reading frame of the 12S rRNA-c.” The peptide was named for its coding sequence, which sits within the 12S ribosomal RNA region of the mitochondrial genome.

How is MOTS-c different from other research peptides?
Most research peptides are encoded by nuclear DNA. MOTS-c is encoded by mitochondrial DNA, which makes it one of a small class of mitochondrial-derived peptides studied in the published preclinical literature. The mitochondrial origin is associated with the AMPK-pathway and mitochondrial-function-marker observations that dominate the published MOTS-c research.

How is MOTS-c reconstituted for laboratory research?
Standard reconstitution uses bacteriostatic water. For a 40mg vial, common research concentrations are 10 mg/mL (4 mL bac water) or 20 mg/mL (2 mL bac water). See our reconstitution guide for the full math.

How long is MOTS-c stable after reconstitution?
Stability is peptide-specific. MOTS-c is typically stored under cold-chain conditions in the laboratory. Reference the validated stability data from the laboratory’s protocol or from the supplier’s batch documentation. Each Pure Chain Aminos research vial ships with the standard lyophilized stability profile on the COA.

Where can I buy MOTS-c with a Certificate of Analysis?
Research-grade MOTS-c with batch-level third-party COA is available at Pure Chain Aminos: MOTS-c 40mg.

“MOTS-c is a 16-amino-acid mitochondrial-derived peptide encoded within the mitochondrial 12S rRNA gene that has been studied in preclinical research models for observed effects on AMPK-pathway activity markers, glucose-homeostasis markers, and mitochondrial-function markers in rodent and cell-culture systems.”
— Pure Chain Aminos Research Team

Disclaimer

MOTS-c and all mitochondrial-derived research peptides sold by Pure Chain Aminos are research peptides for laboratory use only. They are not approved as drugs by the FDA or any other regulatory authority and are not intended to diagnose, treat, cure, or prevent any disease or condition — including any metabolic, mitochondrial, or aging-related condition. Nothing on this page constitutes medical advice. By purchasing, you confirm that you are a qualified researcher operating in a controlled laboratory setting and that you will not administer the compound to any human subject.